Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 325

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 325
---
 (37%), compared to $1,816,425 for the six months ended June 30, 2023. The decrease is primarily due to the net use of cash for operating activities. The balance of cash and cash equivalents for the year ended December 31, 2023, was $1,145,575, representing a decrease of $670,850 (37%), compared to $1,816,425 for the year ended December 31, 2022. The decrease is primarily due to the net use of cash for operating activities. Net Cash Used in Operating Activities Net cash used in operating activities for the six months ended June 30, 2024, was $3,121,258 representing a decrease of $4,190,752 (57%), compared to $7,312,010 for the six months ended June 30, 2023. This decrease was mainly due to the reduction in general and administrative expenses and Kadimastem’s efficiency measures during the period ended June 30, 2024. Net cash used in operating activities for the year ended December 31, 2023, was $3,004,813 representing a decrease of $2,950,385 (49.5%), compared to $5,955,198 for the year ended December 31, 2022. This decrease was mainly due to the reduction in general and administrative expenses and Kadimastem’s efficiency measures during the reporting period which included a reduction in research and development expenses. Net Cash Used in Investing Activities Net cash used in investing activities for the six months ended June 30, 2024, was $112,399, reflecting a decrease of $25,976 (18.7%), compared to $138,375 for the six months ended June 30, 2023. The decrease was mainly attributed to changes in bank deposits during the six months ended June 30, 2023. Net cash received in investing activities for the year ended December 31, 2023, was $90,250, reflecting an increase of $105,120 (53.8%), compared to cash used of $195,370 for the year ended December 31, 2022. The change was mainly attributed to changes in bank deposits during the year ended December 31, 2023. Net Cash Provided by Financing Activities Over the period 2021 -2024, the company raised approximately USD $15.3million in equity for the issuance of 2,146,899shares.